Seed fixity in the prostate/periprostatic region following brachytherapy.
暂无分享,去创建一个
W. Butler | G. Merrick | A. T. Dorsey | J. Lief | M. Benson | G S Merrick | W M Butler | A T Dorsey | J H Lief | M L Benson
[1] K. Wallner,et al. Time-dependent changes in CT-based dosimetry of I-125 prostate brachytherapy. , 1998, Radiation oncology investigations.
[2] D. Kondziolka,et al. Quality assurance for gamma knife stereotactic radiosurgery. , 1995, International journal of radiation oncology, biology, physics.
[3] L. Anderson,et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .
[4] J. Roy,et al. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. , 1995, International journal of radiation oncology, biology, physics.
[5] M A Moerland,et al. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. , 1997, International journal of radiation oncology, biology, physics.
[6] W. Butler,et al. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy. , 1998, Radiation oncology investigations.
[7] W. Butler,et al. Potential role of various dosimetric quality indicators in prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.
[8] M Wannenmacher,et al. Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. , 1988, International journal of radiation oncology, biology, physics.
[9] K. Wallner,et al. CT-based dosimetry for transperineal I-125 prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.
[10] S Nag,et al. Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.
[11] A. Steinfeld,et al. Pulmonary embolization of iodine-125 seeds following prostate implantation. , 1991, Urology.
[12] G S Merrick,et al. Influence of prophylactic dexamethasone on edema following prostate brachytherapy. , 2000, Techniques in urology.
[13] N. Yue,et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. , 1998, International Journal of Radiation Oncology, Biology, Physics.
[14] P. Kumar,et al. Vicryl carrier for I-125 seeds: percutaneous transperineal insertion. , 1986, Radiology.
[15] J J Prete,et al. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.
[16] W. Butler,et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. , 1999, International journal of radiation oncology, biology, physics.
[17] S Nag,et al. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.
[18] R. Stock,et al. A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.
[19] W. Butler,et al. Rectal dosimetric analysis following prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.
[20] T W Griffin,et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.